Vaccine Clinical Trials 2023

Authored by
Last reviewed
September 23, 2023
Content Overview
Alzheimers, Herpes, HIV, dengue, Lyme disease, cancer, yellow fever, and Zika vaccine candidates are conducting clinical trials in 2023

Vaccine Clinical Trials 2023

The development process for new vaccines includes clinical research that involves people like you, says the U.S. National Institutes of Health. When you volunteer to participate in clinical research, you help doctors and researchers learn more about a disease and improve the care for millions of people in the future.

Vaccine Clinical Trial Availability

When developing a new vaccine, the candidate will conduct research studies called phase 1, phase 2, phase 3, and phase 4. Each phase of the development is essential, and all need active participants. offers information about each clinical trial's purpose, who may participate, locations, and more details.

This clinical information should be used in conjunction with advice from healthcare professionals. Top doctors may see you in each category to discuss advanced treatment at no cost to you. Furthermore, financial compensation for participants varies by the type of clinical study. And you can earn compensation for your time and travel. Start your no-cost search today at this sponsored TrialReach link.

Vaccine Clinical Trials and Artificial Intelligence - Machine Learning

In 2023, the U.S. Food and Drug Administration (FDA) recognized the increased use of Artificial Intelligence (AI) and Machine Learning (ML) algorithms throughout the drug development life cycle, including vaccine clinical trials. With more than 100 submissions reported in 2021, these AI/ML submissions traverse the drug development landscape.

As part of this effort, the FDA's Center for Drug Evaluation and Research, in collaboration with the Center for Biologics Evaluation and Research and the Center for Devices and Radiological Health, issued a discussion paper to communicate the use of AI/ML in developing drugs and vaccines.